Search Results for "Abbott Dartford Murex Biotech Ltd"

16:31 EDT 30th August 2014 | BioPortfolio

Original Source: Murex Biotech Limited

Murex Biotech Ltd is part of the diagnostics division and is one of four Abbott sites within the UK. The company has steadily expanded to comprise a total UK workforce of over 2500 employees. At Murex, we are dedicated to the development and manufacture of products for the: detection monitoring screening of infectious diseases and other medical conditions. Murex is based at Dartford, Kent, and its principle focus is a range of enzyme immunoassay products for use by blood transfusion services throughout...

Matching Channels

Abbott

The 11th largest pharmaceutical company in the world, Abbott Laboratories generated sales of $16 billion in 2009 and has 90,000 employees. Within the medical device arm of the company, products of...

Urokinase Abbott

Biotech jobs

The Top 10 Medical Device Companies

Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in...

Czech Republic

Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...

Matching News

Abbott signs a biotech deal with US Defense Department

Abbott and the United States Department of Defense announced a collaboration with the intent to develop portable blood tests to help evaluate potential concussions, also called mild traumatic brain in...

Abbott to acquire Chile's CFR

Abbott Laboratories (NYSE:ABT) will acquire specialty generics company CFR Pharmaceuticals S.A. (Santiago, Chile) for $2.9 billion in cash. Abbott also will assume about $430 million in CFR's net debt...

UPDATE 2-U.S. firm Abbott to buy Russian drugmaker for up to $495 mln

* Gives Abbott manufacturing presence in Russia (Adds background about Abbott, quote)

Abbott Labs Begins Tender Offer For CFR Pharma

NORTH CHICAGO (dpa-AFX) - Diversified healthcare company Abbott Laboratories (ABT) said Monday that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation...

Abbott Declares 362nd Consecutive Quarterly Dividend

ABBOTT PARK, Ill., June 13, 2014 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 22 cents per share. This marks the 362nd consecutive...

Abbott Labs To Buy Russia's Veropharm For More Than $530 Million

Abbott Laboratories and Veropharm have agreed to a non-hostile buyout of the Russia drug maker for more than $530 million, Abbott gaining about 100 drugs in the process.

Abbott Hosts Conference Call for First-Quarter Earnings

ABBOTT PARK, Ill., April 1, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its first-quarter 2014 financial results on Wednesday, April 16, 2014, before the market opens.  The announceme...

Abbott to buy Russian generics firm

US-based pharma company Abbott Laboratories (Abbott) announced on 23 June 2014 that it had signed a definitive agreement to acquire Russian generics maker Veropharm.

Matching PubMed Articles

Biotech methods and advances.

Cover illustration: Our latest Biotech Methods & Advances special issue is edited by our Editors-in-Chief Prof. Alois Jungbauer and Prof. Sang Yup Lee. As always, the special issue is a collection of...

Editorial: Latest methods and advances in biotechnology.

The latest "Biotech Methods and Advances" special issue of Biotechnology Journal continues the BTJ tradition of featuring the latest breakthroughs in biotechnology. The special issue is edited by our...

University biotech patenting 2013.

Public biotech 2013-the numbers.

Benchmarking biotech and pharmaceutical product development.

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement